News | News By Subject | News by Disease News By Date | Search News


Get Our FREE
Industry eNewsletter
Top Breaking News
Why Biogen (BIIB)'s Fate May Depend on Eli Lilly (LLY)'s Alzheimer's Data     10/27/2016
Alkermes (ALKS)' Success Puts the Spotlight on Cerecor, Eli Lilly (LLY)'s 2015 Deal     10/21/2016
Roche (RHHBY)'s Avastin Successor Flunks Key Study, Turns Hope to Tecentriq Instead     10/21/2016
What You May Have Missed: Critics Point to Problems With Celgene (CELG)’s Crohn’s Drug Trial Design     10/20/2016
How Pfizer (PFE) is Quietly Rebuilding Its Alzheimer's Pipeline     10/19/2016
After Hep C Flop, Has Vertex (VRTX) Learned From Its Past Mistakes?     10/18/2016
Comeback Kid Exelixis (EXEL) Could Pose a Huge Threat to Biotech Giants Bristol-Myers Squibb (BMY) and Pfizer (PFE)     10/18/2016
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab     10/18/2016
A Look at CRISPR, 'Biotech's Biggest Discovery of the Century,' and the 3 Companies Knee Deep in It     10/17/2016
3 Biotechs With Cancer Drugs That Could Win Approval in 2017     10/14/2016
ESMO 2016 Takeaways: Don't Miss Celldex (CLDX), Exelixis (EXEL) and Tesaro (TSRO)     10/13/2016
Synairgen (SNG.L) Stock Tanks After Partner AstraZeneca PLC (AZN) Halts Asthma Drug Trial     10/12/2016
Bay Area Exelixis (EXEL)' Cabometyx Beats the Pants Off Pfizer (PFE)'s Sutent in Mid-Stage Kidney Cancer Study     10/11/2016
Clovis Oncology (CLVS) Stock Hammered After Revealing Mixed Results for Rucaparib     10/10/2016
The Ripple Effect of Alnylam (ALNY)'s Blow-up Yesterday     10/10/2016

Featured Stories
A Look at BioMarin (BMRN)'s Potential Blockbuster and the Science Behind It All     10/21/2016
4 Small Biotechs That Could Give Gilead (GILD), Merck & Co. (MRK) Pfizer (PFE) Some Competition With NASH     10/7/2016
Why SCYNEXIS, Inc. (SCYX) Is Making A Run     10/7/2016
Despite Trial Deaths, Juno (JUNO) Could Still Be the CAR-T Leader     9/13/2016
In Juno (JUNO) Patient Deaths, Echoes Seen Of Earlier Failed Company Dendreon (DNDN)     7/11/2016
ASCO2016: What's Next For Cancer-Killing T-Cells After Strong ASCO Showings     6/8/2016
Down's Syndrome 'Can Be Treated With Green Tea,' Centre for Genomic Regulation Study     6/7/2016
Pharma's Big New Cancer Drug May Be An Old Red Dye     2/26/2016
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs     2/10/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Retrenches, And Searches For Answers, After Failed Trial     5/22/2014
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study     2/11/2014
Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?     7/19/2011
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study     1/28/2011
Abbott (ABT) Release: New Study: Babies Fed Infant Formula With 2'-FL Human Milk Oligosaccharide+ Had Immune Response More Like Breastfed Babies     10/27/2016
Results From Shire (SHPG)'s Phase 2 Study Of Maribavir Showed Activity Against CMV Infection In Patients Undergoing Transplant     10/27/2016
DBV Tech Announces Publication Of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study In The Journal Of Allergy And Clinical Immunology     10/27/2016
Medivir (MVRBF): MIV-711 Osteoarthritis Program: Enrollment In The Phase IIa Study Is Complete And Independent Safety Review Committee Again Recommends Go Ahead     10/27/2016
OncoGenex (OGXI) Announces Positive Survival Results From Apatorsen Phase 2 Borealis-2 Trial In Metastatic Bladder Cancer     10/26/2016
ProMetic Life Sci (PFSCF.PK)'s Plasminogen Meets Primary And Secondary End Points In Pivotal Phase 2/3 Trial     10/26/2016
Vertex (VRTX) to Test Next-Generation CF Drugs by End of Year     10/26/2016
National Center for Child Health And Development Initiates Phase 1/2 Trial Of Green Cross' Idursulfase-Beta ICV For The Treatment Of Hunter Syndrome With Neurocognitive Decline     10/26/2016
Vertex (VRTX) Announces Planned Initiation Of Phase 2 Studies Evaluating The Next-Generation Correctors VX-440 And VX-152 In Triple Combination Regimens To Treat The Underlying Cause Of Cystic Fibrosis     10/26/2016
Lexicon Pharma (LXRX) Reports Positive Top-Line Results In Phase 2 Dose-Ranging Study For Sotagliflozin In Patients With Type 1 Diabetes     10/25/2016
Windtree Therapeutics (WINT) Releases Data From Lung Deposition Study In Non-Human Primates Demonstrating Uniform Distribution Of Aerosolized KL4 Surfactant In All Regions Of The Lung     10/25/2016
Bristol-Myers Squibb (BMY) Release: New Results Presented For Opdivo (Nivolumab) Demonstrate Encouraging Response Rate In An Expanded Population Of Heavily Pre-Treated Classical Hodgkin Lymphoma Patients     10/25/2016
Stealth Biotherapeutics Initiates Phase 2 Study Of Elamipretide In Patients Hospitalized With Congestive Heart Failure     10/25/2016
Daiichi Sankyo Release: Anti-HER3 Monoclonal Antibody Patritumab Selected For I-SPY 2 TRIAL In Breast Cancer     10/25/2016
Debiopharm Reaches Important Development Milestones For Its Staphylococcus-Selective Antibiotic Debio 1450     10/25/2016

More News
No News Posted on that date

Career Tips
What You Should Know About Talent Recruitment Cycles in Biopharma     10/26/2016
The 10 Biotech Jobs Most in Demand Through 2024     10/25/2016
A Biotech Recruiter’s Top 4 Need-to-Know Networking Tips     10/24/2016
Paying it Forward: SoCal’s Phenomenex CEO Gives $16,000 to Each Employee     10/21/2016
Salaries for Top Scientists are Skyrocketing But Others are Left Behind     10/20/2016
Researchers With These Two Skill Sets Have a Clear Advantage in the Job Market     10/20/2016
6 Tips for Creating an Eye-Catching Science Resume     10/20/2016
Top 5 Best U.S. Cities for Pharma and Biotech Scientist Jobs     10/20/2016
Industry vs. Academia: Which is the Better Place to Work as a Life Scientist     10/11/2016
Top 5 Best U.S. Cities for Life Science Research Associate Jobs     10/7/2016
Biotech vs. Big Pharma: Which is the Better Place to Work?     9/26/2016
What's Going On With The Biotech Job Market?     9/23/2016
Why People Are Angry at This Wells Fargo Ad About Scientists     9/9/2016
Meet the Next Wave of Scientists Who Are Taking Over Biotech     9/9/2016
These Biotech Employers Hired the Most New Grads In Life Sciences     8/25/2016

Other News Sources